Tumor Tropism of DNA Viruses for Oncolytic Virotherapy
Viruses · 16.11.2023 · 15 (11) · 2262
DOI: 10.3390/v15112262 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Viruses, online erschienen am 16.11.2023. Verfasst von Junior A Enow und 2 weiteren Autor:innen. Beteiligte Einrichtung: Biodesign Center for Personalized Diagnostics, Biodesign Institute, Arizona State University, Tempe, AZ 85287, USA. Hauptthemen laut MEDLINE: Oncolytic Virotherapy, Neoplasms, Herpesvirus 1, Human, Oncolytic Viruses. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NCI NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Oncolytic viruses (OVs) have emerged as one of the most promising cancer immunotherapy agents that selectively target and kill cancer cells while sparing normal cells. OVs are from diverse families of viruses and can possess either a DNA or an RNA genome. These viruses also have either a natural or engineered tropism for cancer cells. Oncolytic DNA viruses have the additional advantage of a stable genome and multiple-transgene insertion capability without compromising infection or replication. Herpes simplex virus 1 (HSV-1), a member of the oncolytic DNA viruses, has been approved for the treatment of cancers. This success with HSV-1 was achievable by introducing multiple genetic modifications within the virus to enhance cancer selectivity and reduce the toxicity to healthy cells. Here, we review the natural characteristics of and genetically engineered changes in selected DNA viruses that enhance the tumor tropism of these oncolytic viruses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Biodesign Center for Personalized Diagnostics, Biodesign Institute, Arizona State University, Tempe, AZ 85287, USA.
- School of Life Sciences, Arizona State University, Tempe, AZ 85287, USA.
ORCID-Profile: Junior A Enow, Masmudur M Rahman
Förderung
- NIAID NIH HHS
- NCI NIH HHS
- National Institute of Allergy and Infectious Diseases
- National Cancer Institute
Zitieren
APA
Enow, J. A., Sheikh, H. I., & Rahman, M. M. (2023). Tumor Tropism of DNA Viruses for Oncolytic Virotherapy. Viruses, 15(11), 2262. https://doi.org/10.3390/v15112262
Vancouver
Enow JA, Sheikh HI, Rahman MM. Tumor Tropism of DNA Viruses for Oncolytic Virotherapy. Viruses. 2023;15(11):2262. doi:10.3390/v15112262
BibTeX
@article{Enow2023,
author = {Enow, Junior A and Sheikh, Hummad I and Rahman, Masmudur M},
title = {Tumor Tropism of DNA Viruses for Oncolytic Virotherapy},
journal = {Viruses},
year = {2023},
volume = {15},
number = {11},
pages = {2262},
doi = {10.3390/v15112262}
}
EUVIMED